SCHEMBL3577943

SCHEMBL3577943

OC1Cc2ccc(F)c3cccc1c23

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3590810 1.00
SCHEMBL3598304 0.79 CYP1A2 (0.36)
SCHEMBL3583212 0.79 CYP1B1 (0.33)
SCHEMBL3590871 0.76 KMT2A (0.46)
SCHEMBL6156286 0.73 LMNA (0.37)
SCHEMBL7883274 0.72 MTNR1A (0.47)
SCHEMBL2240250 0.72 MTNR1A (0.47)
SCHEMBL345448 0.72 MTNR1A (0.47)
Benzene SCHEMBL27878569 0.71 MTNR1A (0.46)
SCHEMBL3595173 0.70 OPRL1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877779-B2 Benzimidazole compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2014-11-04 US disclosed
CN-101622241-B Benzimidazole compound and medical application thereof MITSUBISHI TANABE PHARMA CORP 2013-05-22 CN disclosed
US-20100120841-A1 BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-05-13 US disclosed
CN-101622241-A Benzimidazole compound and medical application thereof MITSUBISHI TANABE PHARMA CORP 2010-01-06 CN disclosed
EP-2128154-A1 BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2009-12-02 EP disclosed